Nippon Kayaku Co., Ltd.

Tokyo Stock Exchange 4272.T

Nippon Kayaku Co., Ltd. Price to Book Ratio (P/B) on January 31, 2025: 0.75

Nippon Kayaku Co., Ltd. Price to Book Ratio (P/B) is 0.75 on January 31, 2025, a -3.18% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Nippon Kayaku Co., Ltd. 52-week high Price to Book Ratio (P/B) is 0.87 on August 01, 2024, which is 16.13% above the current Price to Book Ratio (P/B).
  • Nippon Kayaku Co., Ltd. 52-week low Price to Book Ratio (P/B) is 0.70 on June 28, 2024, which is -6.09% below the current Price to Book Ratio (P/B).
  • Nippon Kayaku Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 0.76.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4272.T

Nippon Kayaku Co., Ltd.

CEO Mr. Atsuhiro Wakumoto
IPO Date Jan. 4, 2000
Location Japan
Headquarters Meiji Yasuda Seimei Building
Employees 5,902
Sector Health Care
Industries
Description

Nippon Kayaku Co., Ltd., together with its subsidiaries, develops, manufactures, and sells functional chemicals, pharmaceuticals, safety systems, and agrochemicals and other products in Japan and internationally. The company's Functional and Chemical Business segment offers functional materials, such as epoxy resins, UV-curable resins, sealants for LCD and LED, maleimide resins, photoresists and insulating materials for micro electromechanical systems, and cleaning agents and chemicals. This segment also provides color materials, including inkjet colorants, dyes for textiles and papers, and materials for thermal paper; catalysts for the production of acrylic and methacrylic acid; and polarizing films, inorganic polarizers, liquid crystal display components and projector parts, and components for x-ray analysis. Its Pharmaceuticals Business segment offers anti-cancer and cancer-related drugs, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drugs and intermediates of pharmaceuticals, and drugs for diagnosing cancer, as well as GlycoMark, a product as a marker of blood sugar control used for diabetes. The company's Safety Systems Business segment provides airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Its Agrochemicals Business segment offers agricultural insecticides, herbicides, soil fumigants, and insanitary insecticides. The company also engages in real estate leasing services. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.

Similar companies

4208.T

UBE Corporation

USD 14.73

-0.89%

4183.T

Mitsui Chemicals, Inc.

USD 22.00

-0.82%

4042.T

Tosoh Corporation

USD 13.34

-0.87%

3401.T

Teijin Limited

USD 8.53

-0.96%

4021.T

Nissan Chemical Corporation

USD 30.19

-1.09%

StockViz Staff

February 1, 2025

Any question? Send us an email